Evidence map›Paper›PMID 28272369›Full record

ReviewMicroorganisms2017

Microbial Biofilms and Chronic Wounds.

Amin Omar, J Barry Wright, Gregory Schultz, Robert Burrell, Patricia Nadworny

Abstract readReview
In one paragraph

Review in Microorganisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Bee sting-induced hypervirulentNew microbes and new infections · 2026
    Review
  7. Article
  8. Review
  9. Development of a Film-Forming Wound Dressing fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  10. Review
  11. Article
  12. A synergistic multimodality treatment approach to address the key drivers of wound chronicity.Journal of vascular surgery. Venous and lymphatic disorders · 2026
    Review
  13. Review
  14. Review
  15. Preparing a Dual-SpeciesMolecular pharmaceutics · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amin OmarInnovotech Inc., Suite 101, 2011 94 Street, Edmonton, Alberta T6N 1H1, Canada. amin.omar@innovotech.ca.
J Barry WrightHarkynn Consulting, P.O. Box 104, Albertville, Saskatchewan S0J 0A0, Canada. jbarry.wright@gmail.com.
Gregory SchultzDepartment of Obstetrics and Gynecology, Institute for Wound Research, University of Florida, 1600 South West Archer Road, Room M337F, Gainesville, FL 32610-0294, USA. schultzg@ufl.edu.
Robert BurrellDepartment of Biomedical Engineering, Faculties of Engineering and Medicine & Dentistry, 1101 Research Transition Facility, University of Alberta, Edmonton, Alberta T6G 2G6, Canada. rburrell@ualberta.ca.
Patricia NadwornyInnovotech Inc., Suite 101, 2011 94 Street, Edmonton, Alberta T6N 1H1, Canada. patricia.nadworny@innovotech.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background is provided on biofilms, including their formation, tolerance mechanisms, structure, and morphology within the context of chronic wounds. The features of biofilms in chronic wounds are discussed in detail, as is the impact of biofilm on wound chronicity. Difficulties associated with the use of standard susceptibility tests (minimum inhibitory concentrations or MICs) to determine appropriate treatment regimens for, or develop new treatments for use in, chronic wounds are discussed, with alternate test methods specific to biofilms being recommended. Animal models appropriate for evaluating biofilm treatments are also described. Current and potential future therapies for treatment of biofilm-containing chronic wounds, including probiotic therapy, virulence attenuation, biofilm phenotype expression attenuation, immune response suppression, and aggressive debridement combined with antimicrobial dressings, are described.

Indexed as

antibiotic resistanceantibiotic toleranceexopolymerinflammationMBEC (minimum biofilm eradication concentration)quorum sensingwound healing

Identifiers

PMID28272369
PMCPMC5374386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.